Background and Objectives. The available data on the immunoglobulin gene (IG) repertoire in multiple myeloma (MM) derive mainly from heavy chains; considerably less is known about light chains. We assessed in parallel IGH and IGK/IGL rearrangements in 101 MM patients so as to gain insight into: (i) IG repertoires; (ii) antigen impact; (iii) the role of receptor editing. Design and Methods. Bone marrow aspirates were collected from all cases. IGHV-(D)-J and IGLV-J rearrangements were amplified by reverse transcriptase polymerase chain reaction (PCR). In all cases, IGKV-J rearrangements were analyzed in parallel on cDNA/genomic DNA. IGKV-KDE and IGKJ-C-INTRON-KDE were also amplified by DNA-PCR. RT-PCR products were directly sequenced. Results...
Multiple myeloma is a heterogeneous disease whose pathogenesis has not been completely elucidated. A...
Introduction Although monoclonal immunoglobulin (Ig) production by myeloma cells is one of the centr...
textabstractThis study involved 12 patients with multiple myeloma (MM), in whom malignant ...
Abstract BACKGROUND: Characterization of the immunoglobulin gene repertoire has improved ou...
BACKGROUND: Characterization of the immunoglobulin gene repertoire has improved our understanding o...
BACKGROUND: Characterization of the immunoglobulin gene repertoire has improved our understanding o...
Background. Characterization of the immunoglobulin genes repertoire improved the understanding of th...
Background. Characterization of the immunoglobulin genes repertoire improved the understanding of th...
Background. Characterization of the immunoglobulin genes repertoire improved the understanding of th...
The ability to rearrange the germ-line DNA to generate antibody diversity is an essential prerequisi...
The ability to rearrange the germ-line DNA to generate antibody diversity is an essential prerequisi...
Multiple myeloma is a heterogeneous disease whose pathogenesis has not been completely elucidated. A...
Multiple myeloma (MM) is a malignant B-cell neoplasm characterized by an uncontrolled proliferation ...
Introduction: Multiple Myeloma (MM) is characterized by genetic heterogeneity and varied clinical co...
The ability to rearrange the germ-line DNA to generate antibody diversity is an essential prerequisi...
Multiple myeloma is a heterogeneous disease whose pathogenesis has not been completely elucidated. A...
Introduction Although monoclonal immunoglobulin (Ig) production by myeloma cells is one of the centr...
textabstractThis study involved 12 patients with multiple myeloma (MM), in whom malignant ...
Abstract BACKGROUND: Characterization of the immunoglobulin gene repertoire has improved ou...
BACKGROUND: Characterization of the immunoglobulin gene repertoire has improved our understanding o...
BACKGROUND: Characterization of the immunoglobulin gene repertoire has improved our understanding o...
Background. Characterization of the immunoglobulin genes repertoire improved the understanding of th...
Background. Characterization of the immunoglobulin genes repertoire improved the understanding of th...
Background. Characterization of the immunoglobulin genes repertoire improved the understanding of th...
The ability to rearrange the germ-line DNA to generate antibody diversity is an essential prerequisi...
The ability to rearrange the germ-line DNA to generate antibody diversity is an essential prerequisi...
Multiple myeloma is a heterogeneous disease whose pathogenesis has not been completely elucidated. A...
Multiple myeloma (MM) is a malignant B-cell neoplasm characterized by an uncontrolled proliferation ...
Introduction: Multiple Myeloma (MM) is characterized by genetic heterogeneity and varied clinical co...
The ability to rearrange the germ-line DNA to generate antibody diversity is an essential prerequisi...
Multiple myeloma is a heterogeneous disease whose pathogenesis has not been completely elucidated. A...
Introduction Although monoclonal immunoglobulin (Ig) production by myeloma cells is one of the centr...
textabstractThis study involved 12 patients with multiple myeloma (MM), in whom malignant ...